ONSERO

Pharmaceutical products for the treatment of health and mental health conditions, in particular depression, anxiety, mood disorders, post-traumatic stress disorders, compulsive disorders and migraines; pharmaceutical products for the treatment of health and mental health diseases and disorders in particular depression, anxiety, mood disorders, post-traumatic stress disorders, compulsive disorders and migraines; pharmaceutical products for the treatment of neurological and psychiatric diseases and disorders; diagnostic agents, preparations, and substances for medical purposes; none of the foregoing including pharmaceutical products in the fields of multiple sclerosis, HIV/AIDS, reproductive health, namely, fertility, or oncology, metabolic diseases, or endocrinological diseases

Pharmaceutical and biopharmaceutical research and development; drug discovery services; laboratory research services relating to pharmaceuticals and diagnostics, namely, research in the fields of health and mental health diseases and disorders, neurological diseases and disorders, and psychiatric diseases and disorders; provision of information and data relating to medical research and development in the fields of health and mental health diseases and disorders, neurological diseases and disorders, and psychiatric diseases and disorders; consultancy in the field of pharmaceutical and pharmaceutical diagnostics research; none of the foregoing including pharmaceutical products in the fields of multiple sclerosis, HIV/AIDS, reproductive health, namely, fertility, or oncology, metabolic diseases, or endocrinological diseases